موافقات الدواء

Bleeding or risk of bleeding with increased fibrinolysis, both generalized and local, in adults and children from 1 year of age.
Specific indications include bleeding caused by increased general or local fibrinolysis, such as:
- menorrhagia and metrorrhagia;
- gastrointestinal bleeding;
- hemorrhagic disorders of the urinary tract after surgery on the prostate gland or surgery or procedures on the urinary tract;
- otolaryngology (adenoid removal, tonsillectomy) and dental (tooth extraction) surgery;
- gynecological operations or complications in obstetric practice;
- thoracic, abdominal and other major surgeries, such as cardiovascular;
- control of hemorrhage after administration of fibrinolytic drug.